Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1. 2014

Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
Wohl Virion Centre and Medical Research Council (MRC) Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, London, United Kingdom.

To date, no immunization of humans or animals has elicited broadly neutralizing sera able to prevent HIV-1 transmission; however, elicitation of broad and potent heavy chain only antibodies (HCAb) has previously been reported in llamas. In this study, the anti-HIV immune responses in immunized llamas were studied via deep sequencing analysis using broadly neutralizing monoclonal HCAbs as a guides. Distinct neutralizing antibody lineages were identified in each animal, including two defined by novel antibodies (as variable regions called VHH) identified by robotic screening of over 6000 clones. The combined application of five VHH against viruses from clades A, B, C and CRF_AG resulted in neutralization as potent as any of the VHH individually and a predicted 100% coverage with a median IC50 of 0.17 µg/ml for the panel of 60 viruses tested. Molecular analysis of the VHH repertoires of two sets of immunized animals showed that each neutralizing lineage was only observed following immunization, demonstrating that they were elicited de novo. Our results show that immunization can induce potent and broadly neutralizing antibodies in llamas with features similar to human antibodies and provide a framework to analyze the effectiveness of immunization protocols.

UI MeSH Term Description Entries
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002161 Camelids, New World Camelidae of the Americas. The extant species are those originating from South America and include alpacas, llamas, guanicos, and vicunas. Alpacas,Guanacos,Llamas,Lama glama,Lama glama guanicoe,Lama guanicoe,Lama pacos,Vicugna pacos,Vicugna vicugna,Vicunas,Alpaca,Camelid, New World,Guanaco,Llama,New World Camelid,New World Camelids,Vicuna
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001666 Binding Sites, Antibody Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS. Antibody Binding Sites,Paratopes,Antibody Binding Site,Binding Site, Antibody,Paratope
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015704 CD4 Antigens 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120. Antigens, CD4,CD4 Molecule,CD4 Receptor,CD4 Receptors,Receptors, CD4,T4 Antigens, T-Cell,CD4 Antigen,Receptors, Surface CD4,Surface CD4 Receptor,Antigen, CD4,Antigens, T-Cell T4,CD4 Receptor, Surface,CD4 Receptors, Surface,Receptor, CD4,Surface CD4 Receptors,T-Cell T4 Antigens,T4 Antigens, T Cell

Related Publications

Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
June 2019, PLoS pathogens,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
May 2012, Journal of virology,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
May 2024, Advanced science (Weinheim, Baden-Wurttemberg, Germany),
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
March 2021, Proceedings of the National Academy of Sciences of the United States of America,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
July 2015, The Journal of general virology,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
October 1994, Molecular immunology,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
February 2019, Journal of virology,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
September 2013, Current opinion in HIV and AIDS,
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
October 2017, Science (New York, N.Y.),
Laura E McCoy, and Lucy Rutten, and Dan Frampton, and Ian Anderson, and Luke Granger, and Rachael Bashford-Rogers, and Gillian Dekkers, and Nika M Strokappe, and Michael S Seaman, and Willie Koh, and Vanina Grippo, and Alexander Kliche, and Theo Verrips, and Paul Kellam, and Ariberto Fassati, and Robin A Weiss
April 2013, The Journal of experimental medicine,
Copied contents to your clipboard!